| Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | HMG-CoA Reductase Inhibitors ending
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | HMG-CoA Reductase Inhibitors work best at |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | breaks down already formed thrombus reestablishes blood flow
 |  | 
        |  | 
        
        | Term 
 
        | Fibric acid derivatives fxn
 |  | Definition 
 
        | hyperglyceridemia decreases GI absorption of cholesterol
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Angiotensin receptor Blockers ending
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Calcium Channel Blockers ending
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Presynaptic Adrenergic Inhibitors fxn
 |  | Definition 
 
        | Inhibits NE release from neurons |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HTN BPH
 Urinarry incontinence
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HTN Angina
 HF
 Atrial Fibrilation
 Post MI
 |  | 
        |  | 
        
        | Term 
 
        | Centrally Acting Agents TU
 |  | Definition 
 
        | HTN Withdrawal from Heroin + coke
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HTN post Mi
 HF
 Diabetic patients
 |  | 
        |  | 
        
        | Term 
 
        | Angiotensin Receptor Blockers TU
 |  | Definition 
 
        | HTN Post MI
 HF
 Diabetic Patients
 |  | 
        |  | 
        
        | Term 
 
        | Calcium Channel Blockers TU
 |  | Definition 
 
        | HTN Angina
 Atrial fibrilation
 subarachnoid hemorrhage
 Raynaud's Phenomenon
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nitrates Angina
 CHF
 pulmonary HTN
 Hypertensive urgency/emergency
 |  | 
        |  | 
        
        | Term 
 
        | 2* prevention of Ischemic stroke meds |  | Definition 
 
        | Aspirin Aggrenox
 Plavis
 Warfain
 |  | 
        |  | 
        
        | Term 
 
        | Skeletal muscle relaxants for spasiticity fxn
 |  | Definition 
 
        | Decrease LMN activity therefore decreasing spasticity in skeletal msucle |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Barbituates Benzodiazepines
 Hydrantions
 Succinimides
 2nd generation agents
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Increase GABA decrease glutamate
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | increase seizure threshold and decrease electrical activity in brane |  | 
        |  | 
        
        | Term 
 
        | Valproic acid + derivatives fxn
 |  | Definition 
 
        | Increases GABA @ higher concentrations blocks sodim channels
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dopamine agonists COMT inhibitors
 |  | 
        |  | 
        
        | Term 
 
        | carbamezapine/oxcarbezepine hydantions
 fxn
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | HMG-CoA reductase inhibitors TU
 |  | Definition 
 | 
        |  |